Explore the science behind combining Semaglutide and Tesofensine in a novel dual-mechanism approach targeting metabolic and central appetite pathways for obesity research.

Explore CJC-1295 without DAC, a GHRH analog that research has investigated natural GH pulses by stimulating pituitary receptors, with insights on its pharmacokinetics, biological effects, and compliant RUO usage for research applications.

Explore how CJC-1295 with DAC extends GH stimulation for up to two weeks, elevating IGF-1 levels. Understand its research-based benefits and FDA-compliant use as a Research Use Only peptide in clinical and wellness practice.